Individual generic drug information
Extracted information for Rilpivirine only.
HIV infection in combination with other antiretroviral drugs in patients not previously treated with antiretroviral therapy and if plasma HIV-1 RNA concentration less than or equal to 100 000 copies/mL ▶BY MOUTH ▶Adult: 25 mg once daily
Source page 705
Acute porphyrias p. 1120
Source page 705
Extracted information for Rilpivirine only.
→Appendix 1: rilpivirine
Source page 705
▶Common or very common Appetite decreased. depression. dizziness. drowsiness. dry mouth. fatigue. gastrointestinal discomfort. headache. nausea. rash. sleep disorders. vomiting ▶Uncommon Immune reconstitution inflammatory syndrome Infection ▶Common or very common Abdominal pain. anaemia (may require transfusion). asthenia. diarrhoea. dizziness. headache. insomnia. nausea. neutropenia. skin reactions . vomiting ▶Uncommon Angioedema. lactic acidosis. pancreatitis ▶Frequency not known Immune reconstitution inflammatory syndrome. osteonecrosis SIDE-EFFECTS, FURTHER INFORMATION Osteonecrosis has been reported in patients with advanced HIV disease or following long-term exposure to combination antiretroviral therapy.
Source page 705
Manufacturer advises avoid unless essential— no information available. Monitoring Mitochondrial dysfunction has been reported in infants exposed to nucleoside reverse transcriptase inhibitors in utero; the main effects include haematological, metabolic, and neurological disorders; all infants whose mothers received nucleoside reverse transcriptase inhibitors during pregnancy should be monitored for relevant signs or symptoms.
Source page 705
Manufacturer advises caution in moderate impairment (limited information available); avoid in severe impairment (no information available). In general, manufacturers advise caution in patients with chronic hepatitis B or C (increased risk of hepatic side-effects). eiiii F 683
Source pages 705, 706
Manufacturer advises caution in severe impairment.
Source page 705
Extracted information for Rilpivirine only.
There can be variation in the licensing of different medicines containing the same drug. Tablet CAUTIONARY AND ADVISORY LABELS 3, 21, 25 ▶Edurant (Janssen-Cilag Ltd) Rilpivirine (as Rilpivirine hydrochloride) 25 mg Edurant 25mg tablets | 30 tablet P £200.27 Combinations available: Dolutegravir with rilpivirine, p. 679. Emtricitabine with rilpivirine and tenofovir alafenamide, p. 687. Emtricitabine with rilpivirine and tenofovir disoproxil, p. 688 ANTIVIRALS › NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS Nucleoside reverse f transcriptase inhibitors
Source page 705
Extracted information for Rilpivirine only.
Patients or carers should be given advice on how to administer rilpivirine tablets. Missed doses If a dose is more than 12 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.
Source page 705
Filter the extracted dose blocks for this individual drug.
First line only; read the complete Indications and dose section above.
25 mg once daily
This is a first-line fragment. Read the full Indications and Dose section above.
Candidate age grouping · source page 705
